We have developed a compact disc (CD)-shaped microfluidic device for multiple, rapid enzyme-linked immunosorbent assays (ELISA). The device has a versatile design that can be adapted for the detection of various proteins by selecting the push-in-type reaction parts and appropriate reagents for each target. In this paper, we report the rapid quantification of insulin, adiponectin, and leptin, which can be used for the early diagnosis of diabetes, in human serum in only 16 min with our device.
Introduction
By quantifying the levels of specific proteins, called biomarkers, in the blood, it is possible to examine various health conditions. In particular, the quantification of multiple biomarkers is important for early and accurate diagnoses. [1] [2] [3] For instance, our research team previously reported that early diagnosis of diabetes is possible by quantifying insulin, adiponectin, and leptin in the blood. 1 Enzyme-linked immunosorbent assays (ELISA) and immunochromatography are widely used for the detection of proteins. Although immunochromatography facilitates rapid detection within 1 min, it has low sensitivity and is not suitable for quantification. 4 On the other hand, ELISA takes more time and require greater skill, but generates results that are suitable for quantification with high sensitivity. Therefore, in order to enable rapid detection, several research groups have developed ELISA systems that apply microfluidic technology. [5] [6] [7] These microfluidic systems have some advantages, such as reducing the amount of reagent, shortening the reaction time, and miniaturizing the apparatus. Especially, some compact disc (CD)-shaped microfluidic devices aiming for field diagnosis at point-of-care-testing (POCT) have been developed, because parallel reactions by a single motor and an automated system can be realized. [8] [9] [10] [11] Park et al. reported the simultaneous detection of 3 kinds of proteins in 20 min using a CD-shaped microfluidic device. 11 However, only two samples could be measured simultaneously, because their device was necessary to make wide areas for stocking all of the reagents on a thin disc. Furthermore, a calibration curve could not be created simultaneously when the sample was measured.
In this paper, we fabricated the cartridge with reagent reservoirs and separated it from the main microchannel, so we could detect 15 samples in an assemble disc. In addition, the calibration curve for accurate quantification could be created simultaneously when the samples were measured because the number of measureable samples had increased in an assemble disc. We measured the multimarkers for the early diagnosis of diabetes (insulin, adiponectin, and leptin) using this novel system.
Experimental

Reagents and chemicals
Monoclonal antibodies for the solid phase (capture) and detection of insulin, adiponectin, and leptin were purchased from Mikuri Immunology Laboratory (Osaka, Japan). A peroxidase labeling kit-NH2 (Dojindo Molecular Technologies, Kumamoto, Japan) was used for horseradish peroxidase (HRP) labeling of the detection antibodies. For immobilization of a solid phase antibody, we used 100 mM sodium carbonate buffer (pH 9.6). Block Ace (DS Pharma Biomedical, Osaka, Japan) was used to block any nonspecific adsorption of proteins. We used a washing buffer comprising 9.57 mM phosphate-buffered saline (PBS) with 0.05% TWEEN Standards Laboratory (Osaka, Japan). We used adiponectin that had been expressed in E. coli and purified in our laboratory. For leptin, Active human Leptin full-length protein was purchased from Abcam (Cambridge, UK). SuperSignal TM West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific, Yokohama, Japan) was used as the luminescent substrate, and luminescence was measured with an LAS-3000 Mini (Fujifilm, Tokyo, Japan). Obesity Control A, B, C/Human and Diabetes Antigen Control (Low, High)/Human were purchased from Mercodia (Uppsala, Sweden) and used as control sera. Figure 1 depicts the CD-shaped microfluidic device developed in this study. The device consisted of 6 layers: a pressuresensitive adhesive (PSA) layer with loading holes (Layer 1), a polymethyl methacrylate (PMMA) disc with reagent reservoirs (Layer 2), an adhesive layer with loading holes, which was necessary for attaching layer 2 to layer 4 (Layer 3), a PSA layer with loading holes (Layer 4), a PMMA disc with microchannels (Layer 5), push-in-type PMMA parts for the reactions (Layer 6). The PMMA disc with microchannels (105 mm in diameter and 2 mm in thickness) was fabricated by injection molding (ShinEtsu Polymer, Tokyo, Japan). The reagents in chamber 1 and chamber 2 were sent to the reaction chamber and any excess was discharged to waste 1 at low-speed rotation (1000 rpm). Then, at high-speed rotation (2250 rpm), the reagents remaining in the reaction chamber were discharged to waste 2 through the narrow microchannels leading toward the outer edge of the disc. A PMMA disc with reagent reservoirs (Layer 2; 52 mm in diameter and 4 mm in thickness) was fabricated with a cutting machine (Micro MC-3, PMT Corporation, Fukuoka, Japan). The PMMA disc with the reagent reservoirs also had two kinds of holes; small holes provided access to chambers of the PMMA disc with the microchannels, and big holes provided access to introduce the samples and the common washing buffer for each reaction (Layer 5). In this study, simultaneous detection of 15 samples on one CD-shaped microfluidic device was realized by separating the reagent reservoirs (Layer 2) from the main microchannels (Layer 5). The push-in-type PMMA parts for the reactions (Layer 6) were attached to the PMMA disc with the microchannels (Layer 5), after immobilization of the solidphase antibodies and a blocking treatment to suppress nonspecific adsorption of proteins.
CD-shaped microfluidic device
Rapid ELISA for insulin, adiponectin, and leptin in human serum
In this study, sandwich-type ELISA was performed in the CDshaped microfluidic device to realize rapid protein detection. The schematic diagram of sandwich-type ELISA in our device is shown in Fig. S1 (Supporting Information). To prepare for the rapid ELISA in the CD-shaped microfluidic device, each of the solid-phase antibodies was incubated in a 100 mM sodium carbonate buffer (pH 9.6) at 37 C for 1 h to facilitate antibody immobilization on the PMMA parts for reaction. Then, the PMMA parts were incubated with 4% Block Ace in 9.57 mM PBS (pH 7.6) at room temperature (about 25 C) for 1 h to suppress nonspecific adsorption of proteins. The PMMA reaction parts with the immobilized solid-phase antibody and the PMMA disc with the reagent reservoirs, which contained the HRP-conjugated detection antibody and luminescent substrate, were mounted on the PMMA disc with the microchannels.
For rapid ELISA in the CD-shaped microfluidic device, 10 μL of the sample was introduced from the through hole to chamber 1. The sample was sent to the reaction chamber by rotation at 1000 rpm for 10 s, and incubated at room temperature for 5 min. Then, 10 μL of PBST was introduced from the through hole to chamber 1, and sent to the reaction chamber by rotation at 1000 rpm for 10 s, in order to wash the reaction chamber. In this study, the washing step could be performed efficiently by washing once each with 3 buffers with different specific Fig. 1 Schematic of the CD-shaped microfluidic device. It consists of 6 layers containing 3 elements: the microchannels, the reagent reservoirs, and the parts for reaction.
gravities, based on their glycerol densities.
Figure S2 (Supporting Information) indicates the cleaning efficiency for the fluorescent reagent in a washing buffer with 25% glycerol. The washing step was performed at 1000 rpm for 10 s. By washing with a solution having a specific gravity larger than that of the solution contained in the reaction chamber, the efficient washing is possible by pushing out the solution contained the reaction chamber to the waste 1 from the microchannel provided on the central portion side of the reaction chamber. The tertiary washing buffer was discharged to waste 2 by rotation at 2250 rpm for 30 s. By opening a hole with a needle at the position for vent 1 in the PSA layer and rotating at 1000 rpm for 10 s, the HRP-conjugated detection antibody was sent to the reaction chamber from reagent reservoir 1 and incubated at room temperature for 5 min. In the same manner, washing was performed 3 times and the tertiary washing buffer was discharged at 2250 rpm for 30 s. By opening a hole with a needle at the position of vent 2 in the PSA layer and rotating at 2000 rpm for 5 s, the luminescent substrate was sent to the reaction chamber from reagent reservoir 2. The solution control by rotation and opening the vent were performed by a device under development with our industrial partner in Fig. S3A (Supporting Information). Immediately after introducing the luminescent substrate to the reaction chamber, the luminescence intensity of the whole CD-shaped device was measured for three min in the high-resolution mode by an image analyzer (LAS-3000, Fujifilm, Tokyo, Japan). Then, the luminescence intensity of the reaction parts was excised and quantified by Multi GaugeImage, which was the attached software for LAS-3000.
Results and Discussion
In order to confirm accurate measurement by our CD-shaped microfluidic device, we measured the concentrations of insulin, adiponectin, and leptin using human serum samples. We first investigated the reaction time required for the rapid ELISA in our device. As shown in Fig. S4 (Supporting Information) , when the both reaction times of the sample and the HRPconjugated detection antibody were 5-min or more, the luminescent intensity increased according to the concentration of the protein. Therefore, we selected a 5-min reaction time for this study. Figure 2 indicates a comparison between the values measured by our rapid ELISA on the CD-shaped microfluidic device and the values described in the guarantees for the control sera. These measured values are shown as the result of measuring each protein on one CD-shaped microfluidic device. These standard deviations (SD) were calculated from the results measured using 6 microchannels in one CD-shaped microfluidic device. Although the SD with our device were slightly larger than those of the guarantee, we detected 3 proteins in the serum with our device. The recovery rates of each sample are indicated in Table S1 (Supporting Information).
In our device, as the diffusion distance was shortened by thinning the distance between the reaction part and the PSA layer by 100 μm, the rapid ELISA was accomplished in 16 min, which was the total time required for introduction of washing buffer, HRP conjugated detection antibody and luminescence substrate, and luminescence measurement by an image analyzer after sample introduction. As a rapid ELISA by a CD-shaped microfluidic device, Park et al. accomplished the detection for three kinds of proteins in 20 min. 11 In their method, although the diffusion distance from the bead surface to the liquid surface was several millimeters, the efficient binding between proteins in the solution and the capture antibodies on the beads surface was promoted by the mixing mode during which their disc repeats the cycle of acceleration and deceleration (±1200 rpm/s). On the other hand, our method achieved a faster reaction by shortening the diffusion distance without mixing to within 16 min. Furthermore, the cost of the reagents for our assay would be lower than that for a conventional ELISA, because our device uses 10 to 20-times less reagent (10 μL). In this study, we achieved multiple, rapid ELISA and quantitated the concentration of insulin, adiponectin, and leptin in human serum to within 16 min. Since our device has separate main microchannels, reaction chambers, and reagent reservoirs, it could be easily applied for the quantification of various proteins by the use of appropriate antibodies. We are currently developing a system using our device for fully automatic detection after sample introduction, in cooperation with an industrial partner. As shown in Fig. S3B (Supporting Information), in the developing system, the common washing buffer for ELISA would be automatically introduced by an auto sampler composed in the system. In addition, it would also have an opening hole mechanism for venting when introducing the solution from the reagent reservoirs. The luminescence intensity would be measured by photomultiplier (PMT) in the system. Using this developing system, all steps for rapid ELISA on our device would perform automatically after sample introduction. Therefore, we expect our device to be highly versatile.
Conclusions
We realized multiple, rapid ELISA in a CD-shaped microfluidic device and quantitated the concentrations of insulin, adiponectin, and leptin in human serum within 16 min. We expect our device to be applied to multiple biomarker measurements for accurate diagnosis by using various biomarker-specific antibodies.
